BlackRock lifts Hengrui H-shares stake to 7.21% from 5.92%
HKEX shows BlackRock increased its long position in H-shares of Jiangsu Hengrui Pharmaceuticals to 7.21% on Sep 2, up from 5.92%.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.